# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Ben Hendrix reiterates CVS Health (NYSE:CVS) with a Outperform and maintains $68 price target.
The first night of the Democratic National Convention (DNC) could have investors eyeing sectors like healthcare and automotive ...